Clinical trials, between science and financial and academic interests
Pierre Chirac
The Crash team was delighted to welcome Pierre Chirac, pharmacist and editor of the magazine Prescrire, for a conference on his analysis of the pharmaceutical industry's influence strategies and the special interests of university hospital researchers, their consequences on the reliability of drug information and the means now required to rectify a harmful situation. This meetting was prepared and moderated by Rony Brauman.
On May 22, the Lancet published a peer-reviewed article based on an analysis of 96,000 Covid patient files, which concluded that hydroxychloroquine was ineffective. A few days later, researchers published a letter questioning the methodology and data used by the Surgisphere company to develop this conclusion, and on June 4, the Lancet withdrew the article from publication. This was the beginning of what some people call "Lancetgate", or the "Surgisphere Scandal".
Beyond the frenzy of scientific publications triggered by the Covid-19 outbreak (47,000 in three months!), this event highlighted the questionable reliability of clinical trials. In September 2009, the scientific journal PloS Medicine argued that most trials of new drugs, including those supposedly authored by academic physicians, are subject to frequent manipulation. The title of their editorial clearly indicates scorn: Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger, and the piece specifically outlines the influence and power of drug manufacturers in the clinical research process. Yet the poor quality studies published by French hospital doctors on hydroxychloroquine, even with no link to pharmaceutical companies, show that the problem goes far beyond that of trials financed by 'Big Pharma'.
To cite this content :
Pierre Chirac, “Clinical trials, between science and financial and academic interests”, 8 octobre 2020, URL : https://msf-crash.org/en/conferences-debates/clinical-trials-between-science-and-financial-and-academic-interests
If you would like to comment on this article, you can find us on social media or contact us here:
Contribute
Daro Sulakauri
Opinion
No credit for Drs Knock
12/01/2009Pharmaceutical companies produce drugs and are increasing involved in the clinical trials of these products. This conflict of interest is incompatible with the expectations of Public Health. Rony Brauman suggests that the industry no longer be responsible for therapeutic trials.
Giorgos Moutafis
Analysis
Postface à l’ouvrage "Médiator 150mg"
06/30/2010Ce texte est une postface au livre du Dr Irène Frachon Médiator, 150mg dont le sous-titre « Combien de morts ?», a été retiré à la suite d'une plainte du laboratoire Servier, producteur du médicaments incriminé. Rony Brauman y aborde la question du poids croissant des compagnies pharmaceutiques dans les décisions de santé publique.
Aurelie Baumel
Interview
Santé mondiale. L’évolution vers la privatisation
12/01/2014Pour Rony Brauman, la question de la santé globale se caractérise d'abord et avant tout par la circulation des agents infectieux et toxiques qui relève d'une action mondiale.
Past events
Conference
How to improve access to care and aid for people living with a handicap in a humanitarian context?
04/07/2022 - 06:30 PM 08:30 PMThe Crash team was pleased to invite you to the screening-debate of the film Agir contre l'exclusion, on April 7, 2022. The event was prepared and moderated by Elba Rahmouni.
Conference
Reconstructing Lives
02/17/2022 - 06:30 PM 08:30 PMThe members of the Crash team were happy to welcome you all to an conference-debate with anthropologist Vanja Kovačič, on Thursday 17th of February. The author introduced her recently-published book "Reconstructing lives Victims of war in the Middle East and Médecins Sans Frontières" (Manchester University Press, translated in French and Arabic). This event, prepared with Jean-Hervé Bradol, was moderated by Michaël Neuman.
Conference
Another approach to well-being at work
12/09/2021 - 06:30 PM 08:30 PMThe members of the Crash were very happy to welcome you all to this conference-debate with occupational psychologists Yves Clot and Jean-Yves Bonnefond, two of the authors of “Le prix du travail bien fait – La coopération conflictuelle dans les organisations” (Paris, La Découverte, 2021 ; co-written with Antoine Bonnemain and Mylène Zittoun). This event, prepared with Judith Soussan, was moderated by Clément Perrin.
msf
Conference
Book launch event - Violences extrêmes. Enquêter, secourir, juger République démocratique du Congo, Rwanda, Syrie
11/17/2021 - 06:30 PM 08:30 PMWe were happy to welcome Claudine Vidal, sociologist (CNRS) and Crash scientific committee member, and Jean-Hervé Bradol, doctor, former President of the French section of MSF and current director studies at the Crash, for the launching event of the newly-published book “Violences extrêmes. Enquêter, secourir, juger République démocratique du Congo, Rwanda, Syrie” (Éditions de la Maison des sciences de l’homme, Paris 2021). The event was hosted by Rony Brauman.
Conference
Round Table - 50 years of Doctors without borders (Médecins sans frontières)
11/03/2021 - 07:30 PM 09:00 PMMédecins Sans Frontières celebrated its 50th anniversary. On this occasion and in the framework of the International Humanitarian Studies Association (IHSA) conference, the Crash organized a Round Table on the history of the organization, the myths surrounding it, and its recent evolution. This meeting, prepared with Elba Rahmouni, was moderated by Bertrand Taithe.
Conference
Asylum and exile. A history of the distinction between migrants / refugees
04/12/2021 - 06:30 PM 08:30 PMOn April 12 2021, we were delighted to welcome Karen Akoka, political scientist and sociologist, fresh from her publication in November of “Asylum and Exile. A History of the Refugee/Migrant Distinction" (La Découverte, 2020). The author described and analyzed the trajectory of OFPRA, the French institution founded in 1952 and responsible for granting refugee status; she provided an insight into how the history of the distinction between migrants and refugees was established in France. This conference was prepared and moderated by Michaël Neuman.